INT expresses and presents tumor-specific antigens (TSAs) or tumor-associated antigens (TAAs) to the immune system by encoding them, but their efficacy highly depends on the ability of MHC class I molecules to present antigenic peptides to CD8+ T cells [67]. The gene discussed is CD8A; the disease is neoplasm.